Pisgah Laboratories, Inc.
Records under this name other than the patents Pisgah Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Pisgah Laboratories, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,748,416 | Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties Lapsed on the fee record Ended Jun 10, 2026 · USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | USPTO record |
| US 8,569,329 | Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Lapsed on the fee record Ended Oct 29, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | USPTO record |
| US 8,569,330 | Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Lapsed on the fee record Ended Oct 29, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | USPTO record |
| US 8,476,291 | Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties Lapsed on the fee record Ended Jul 2, 2025 · USPTO record | Lapsed on the fee record | Ended Jul 2, 2025 | USPTO record |
| US 8,367,693 | Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties Lapsed on the fee record Ended Feb 5, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | USPTO record |
| US 8,338,444 | Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties Lapsed on the fee record Ended Dec 25, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2024 | USPTO record |
| US 8,334,322 | Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance Lapsed on the fee record Ended Dec 18, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 18, 2024 | USPTO record |
| US 8,329,720 | Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties Lapsed on the fee record Ended Dec 11, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 11, 2024 | USPTO record |
| US 8,980,880 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Lapsed on the fee record Ended Mar 17, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 17, 2023 | USPTO record |
| US 8,957,067 | Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder Lapsed on the fee record Ended Feb 17, 2023 · USPTO record | Lapsed on the fee record | Ended Feb 17, 2023 | USPTO record |